United States · Who invested in Corvus Pharmaceuticals?
Corvus Pharmaceuticals's investors include OrbiMed, Fidelity, BlackRock, Adams Street Partners and Cormorant Asset Management.
201620182020202220242026
$34MSeries A$75MSeries B$201MRoundUnited States · Funded startup
Who invested in Corvus Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$310Mraised across 3 rounds since 2014, from 3 sources
$34MSeries A$75MSeries B$201MRound
- Latest round
- Round, $201MJan 2026
- Step-upi
- 2.7×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $34M Dec 2014
- Biggest round
- $201M Round · Jan 2026
- Usual gap between rounds
- 10.3 years the median of 2
The rounds
- Jan 2026Round$201M4 new1 returning
Source recorded
- Sept 2015Series B$75M
No investor was named in the report.
From a historical funding recordSEC filing: $75M sold, first sale Sept 2015
- Dec 2014
Founders and team
From Corvus Pharmaceuticals's own website and the SEC filings it signed: 2 founders, 7 on the team.
David MooreCo-Founder
Richard A. van den BroekCo-Founder
- Gabriel LucianoVice President Clinical Operations
- Jeffrey ArcaraChief Business Officer
- Leiv P. LeaChief Financial Officer
- Clinical ScientistDirector/Senior Director Drug Product Development and Manufacturing
- Governance DocumentsBoard of Directors
- Job PostingsAssociate Director Analytical Development & Quality Control
- Richard A. MillerExecutive Officer, Directori
On the board, as filediElisha (Terry) P. GouldPeter P. MoldtPeter P. Thompson
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2014Series B2015Round2026
OrbiMedFidelity
BlackRock
Adams Street Partners
Cormorant Asset Management
OrbiMedFidelityBlackRockAdams Street PartnersCormorant Asset ManagementEveryone who backed them
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Corvus Pharmaceuticals
How much has Corvus Pharmaceuticals raised?
Corvus Pharmaceuticals has raised $310M across 3 rounds since 2014.
When did Corvus Pharmaceuticals last raise?
Corvus Pharmaceuticals's most recent round was an Undisclosed round of $201M in Jan 2026.
What was Corvus Pharmaceuticals's biggest round?
Its most recent round, $201M in Jan 2026, is also its largest on record.
Who backed Corvus Pharmaceuticals first?
Corvus Pharmaceuticals's first round on record, in Dec 2014, was backed by OrbiMed.
What stage is Corvus Pharmaceuticals at?
Corvus Pharmaceuticals's latest named round is an Undisclosed round, in Jan 2026.
Where is Corvus Pharmaceuticals based?
Corvus Pharmaceuticals is based in the United States.
Companies like Corvus Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.